Intas Pharma is planning to raise R2. 50Cr PE investment for expansion

Intas Pharma is planning to raise R250Cr private equity investment for expansion.

Intas Pharma filed DRHP to raise upto R425Cr through fresh issue of shares.

The company planning to use the funds raised through fresh issue for product registration (R108.5Cr), capital expenditure (R218.75Cr) and for other corporate purposes.